The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / A Moment for Reflection
Live Events Professional Development Voices in the Community Profession

A Moment for Reflection

Gregory G. Davis reflects on a year of challenges and optimism as President of ASCP

By Gregory G. Davis 11/02/2026 Opinion 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll

Share

Objective:

Reflect on the author’s ASCP presidency, organizational priorities, and upcoming transition at the next Annual Meeting.

Approach:
  • Presidential year: The author describes the 2025 Annual Meeting in Atlanta, the CEO search, and the Board’s selection of interim CEO Ali Brown as ASCP’s full-time CEO.
  • Challenges and priorities: The article notes concerns about reimbursement cuts, confidence in standard medical practices, the affordability of new technologies, and recruitment of future practitioners.
  • Organizational work: The author discusses collaboration with other professional societies, development of a new strategic plan, and plans for a Governance Committee to replace the Bylaws Committee.
Key Findings:
  • Ali Brown was elected ASCP’s full-time CEO and is the first woman to hold the position.
  • ASCP leaders have begun work on a new strategic plan and a Governance Committee.
  • The next meeting in Montréal will be ASCP’s first international meeting, held in partnership with the Canadian Association for Pathologists (CAP-ACP).
Interpretation:

The author expresses optimism about ASCP’s future, citing collaboration across professional societies, the strategic-planning process, and the Society’s financial and professional resources.

Limitations:
  • This is a first-person presidential reflection, not a research study; it provides no methods or quantitative outcome data.
Conclusion:

The author’s term ends at the Montréal meeting, while ASCP’s work to improve pathology and laboratory medicine practice continues.

Sources:
  • Provided article context

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Gregory G. Davis

President of the American Society for Clinical Pathology

More Articles by Gregory G. Davis

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.